West LA Times

GT Biopharma Inc issued the following announcement on May 12. 

GT Biopharma, Inc. (NASDAQ: GTBP), an immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary tri-specific natural killer (NK) cell engager, TriKE® protein biologic technology platform, announced that management will present at H.C. Wainwright’s Hybrid Global Investment Conference. The conference will take place May 23-26, 2022 at the Fontainebleau, Miami Beach Hotel, Miami Beach, Florida.

H.C. Wainwright Global Investment Conference – May 23-26, 2022
Title:	GT Biopharma (GTBP) Company Presentation
Date:	Tuesday, May 24, 2022
Time:	2:00 - 2:30 PM EDT
Webcast Link:	Register here

                        *a replay of the presentation will be available for 90 days

If you are interested in arranging a 1x1 meeting request with management, please contact your bank conference representative. To access the archived recording for replay, please see the Presentations section of GT Biopharma’s corporate website.

Original source can be found here.